NCT06827691

Brief Summary

The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
21mo left

Started May 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
May 2025Jan 2028

First Submitted

Initial submission to the registry

February 4, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 14, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

2.6 years

First QC Date

February 4, 2025

Last Update Submit

February 10, 2025

Conditions

Keywords

heat therapycardiovascular healthendothelial functionheat intervention

Outcome Measures

Primary Outcomes (3)

  • Maximum Walking Distance

    Maximal walking distance a participant can walk, through a graded treadmill test.

    Baseline to 8 weeks to 16 weeks

  • Pain Free Walking Distance

    Maximum distance participant can walk without pain (IC)

    Baseline to 8 weeks to 16 weeks

  • Time for Onset of Claudication

    Amount of time able to walk pain free before reaching claudication

    Baseline to 8 weeks to 16 weeks

Secondary Outcomes (12)

  • VascuQoL-6

    Baseline to 8 weeks to 16 weeks

  • SF-36

    Baseline to 8 weeks to 16 weeks

  • EQ-5D-5L

    Baseline to 8 weeks to 16 weeks

  • Markers of Inflammation

    Baseline to 8 weeks to 16 weeks

  • Markers of Vascular Remodelling

    Baseline to 8 weeks to 16 weeks

  • +7 more secondary outcomes

Other Outcomes (4)

  • Intervention feasibility assessed via recruitment rate

    through study completion, an average of 1 year

  • Intervention feasibility assessed via protocol adherence

    through study completion, an average of 1 year

  • Intervention acceptability via workshop interviews

    through study completion, an average of 1 year

  • +1 more other outcomes

Study Arms (2)

Wait-list control

NO INTERVENTION

Usual care 8 weeks

Heat Therapy Intervention

ACTIVE COMPARATOR

Heat therapy intervention through water submersion in a hot tub at \~40°C.

Other: Heat Therapy Intervention

Interventions

Heat Therapy Intervention of shoulder depth submersion in a 40°C hot tub.

Heat Therapy Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged \> 18 years
  • ABPI \< 0.9 at rest or a drop of 20mmHG after exercise testing
  • Diagnosed with IC
  • Able to walk unaided
  • English-speaking and able to follow instructions
  • No previous history of heat syncope
  • Post-Menopausal or not on hormone therapy
  • Able to provide informed consent

You may not qualify if:

  • Walking impairment for a reason other than PAD
  • Critical limb ischaemia/rest pain
  • Asymptomatic PAD
  • Active cancer treatment
  • Clinically diagnosed diabetes or those with peripheral neuropathy
  • Recent / frequent heat exposure (e.g., sauna or hot tubs).
  • severe aortic stenosis, unstable angina, recent MI, stroke or TIA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester Metropolitan University

Manchester, United Kingdom

Location

MeSH Terms

Conditions

Peripheral Arterial DiseaseIntermittent ClaudicationPeripheral Vascular DiseasesHyperthermia

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBody Temperature ChangesHeat Stress DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised wait-list controlled feasibility trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2025

First Posted

February 14, 2025

Study Start

May 1, 2025

Primary Completion (Estimated)

November 20, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations